About 2.3 million people in South Africa were living with type 2 diabetes in 2015 accounting for 7% of the population. This number is projected to increase to 4 million by 2035, a 55% increase in prevalence, the biggest driver being obesity. Type 2 diabetes is a chronic, progressive condition and long term complications include strokes, heart attack, and cardiovascular death, as well as diabetic kidney disease, retinopathy, arm and leg amputation, and autonomic neuropathy. In addition to the now marketed products from our own R & D we are also focussed cardio-metabolic indications with a high unmet medical need.